Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

β-Catenin Mutations: Insights into the APC Pathway and the Power of Genetics.

Morin PJ, Kinzler KW, Sparks AB.

Cancer Res. 2016 Oct 1;76(19):5587-5589. No abstract available.

2.

Accurate whole-genome sequencing and haplotyping from 10 to 20 human cells.

Peters BA, Kermani BG, Sparks AB, Alferov O, Hong P, Alexeev A, Jiang Y, Dahl F, Tang YT, Haas J, Robasky K, Zaranek AW, Lee JH, Ball MP, Peterson JE, Perazich H, Yeung G, Liu J, Chen L, Kennemer MI, Pothuraju K, Konvicka K, Tsoupko-Sitnikov M, Pant KP, Ebert JC, Nilsen GB, Baccash J, Halpern AL, Church GM, Drmanac R.

Nature. 2012 Jul 11;487(7406):190-5. doi: 10.1038/nature11236.

3.

Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18.

Norton ME, Brar H, Weiss J, Karimi A, Laurent LC, Caughey AB, Rodriguez MH, Williams J 3rd, Mitchell ME, Adair CD, Lee H, Jacobsson B, Tomlinson MW, Oepkes D, Hollemon D, Sparks AB, Oliphant A, Song K.

Am J Obstet Gynecol. 2012 Aug;207(2):137.e1-8. doi: 10.1016/j.ajog.2012.05.021. Epub 2012 Jun 1.

PMID:
22742782
4.

Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18.

Sparks AB, Struble CA, Wang ET, Song K, Oliphant A.

Am J Obstet Gynecol. 2012 Apr;206(4):319.e1-9. doi: 10.1016/j.ajog.2012.01.030. Epub 2012 Jan 26.

PMID:
22464072
5.

Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy.

Sparks AB, Wang ET, Struble CA, Barrett W, Stokowski R, McBride C, Zahn J, Lee K, Shen N, Doshi J, Sun M, Garrison J, Sandler J, Hollemon D, Pattee P, Tomita-Mitchell A, Mitchell M, Stuelpnagel J, Song K, Oliphant A.

Prenat Diagn. 2012 Jan;32(1):3-9. doi: 10.1002/pd.2922. Epub 2012 Jan 6.

6.

The mutation spectrum revealed by paired genome sequences from a lung cancer patient.

Lee W, Jiang Z, Liu J, Haverty PM, Guan Y, Stinson J, Yue P, Zhang Y, Pant KP, Bhatt D, Ha C, Johnson S, Kennemer MI, Mohan S, Nazarenko I, Watanabe C, Sparks AB, Shames DS, Gentleman R, de Sauvage FJ, Stern H, Pandita A, Ballinger DG, Drmanac R, Modrusan Z, Seshagiri S, Zhang Z.

Nature. 2010 May 27;465(7297):473-7. doi: 10.1038/nature09004.

PMID:
20505728
7.

Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays.

Drmanac R, Sparks AB, Callow MJ, Halpern AL, Burns NL, Kermani BG, Carnevali P, Nazarenko I, Nilsen GB, Yeung G, Dahl F, Fernandez A, Staker B, Pant KP, Baccash J, Borcherding AP, Brownley A, Cedeno R, Chen L, Chernikoff D, Cheung A, Chirita R, Curson B, Ebert JC, Hacker CR, Hartlage R, Hauser B, Huang S, Jiang Y, Karpinchyk V, Koenig M, Kong C, Landers T, Le C, Liu J, McBride CE, Morenzoni M, Morey RE, Mutch K, Perazich H, Perry K, Peters BA, Peterson J, Pethiyagoda CL, Pothuraju K, Richter C, Rosenbaum AM, Roy S, Shafto J, Sharanhovich U, Shannon KW, Sheppy CG, Sun M, Thakuria JV, Tran A, Vu D, Zaranek AW, Wu X, Drmanac S, Oliphant AR, Banyai WC, Martin B, Ballinger DG, Church GM, Reid CA.

Science. 2010 Jan 1;327(5961):78-81. doi: 10.1126/science.1181498. Epub 2009 Nov 5.

8.

The genomic landscapes of human breast and colorectal cancers.

Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PA, Kaminker JS, Zhang Z, Croshaw R, Willis J, Dawson D, Shipitsin M, Willson JK, Sukumar S, Polyak K, Park BH, Pethiyagoda CL, Pant PV, Ballinger DG, Sparks AB, Hartigan J, Smith DR, Suh E, Papadopoulos N, Buckhaults P, Markowitz SD, Parmigiani G, Kinzler KW, Velculescu VE, Vogelstein B.

Science. 2007 Nov 16;318(5853):1108-13. Epub 2007 Oct 11.

9.

Using the transcriptome to annotate the genome.

Saha S, Sparks AB, Rago C, Akmaev V, Wang CJ, Vogelstein B, Kinzler KW, Velculescu VE.

Nat Biotechnol. 2002 May;20(5):508-12.

PMID:
11981567
10.

Mutation screening of the TNFRSF11A gene encoding receptor activator of NF kappa B (RANK) in familial and sporadic Paget's disease of bone and osteosarcoma.

Sparks AB, Peterson SN, Bell C, Loftus BJ, Hocking L, Cahill DP, Frassica FJ, Streeten EA, Levine MA, Fraser CM, Adams MD, Broder S, Venter JC, Kinzler KW, Vogelstein B, Ralston SH.

Calcif Tissue Int. 2001 Mar;68(3):151-5.

PMID:
11351498
11.

Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.

Wilentz RE, Su GH, Dai JL, Sparks AB, Argani P, Sohn TA, Yeo CJ, Kern SE, Hruban RH.

Am J Pathol. 2000 Jan;156(1):37-43.

12.

CDX2 is mutated in a colorectal cancer with normal APC/beta-catenin signaling.

da Costa LT, He TC, Yu J, Sparks AB, Morin PJ, Polyak K, Laken S, Vogelstein B, Kinzler KW.

Oncogene. 1999 Sep 2;18(35):5010-4.

13.

Identification of c-MYC as a target of the APC pathway.

He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW.

Science. 1998 Sep 4;281(5382):1509-12.

14.

Mapping the specificity of SH3 domains with phage-displayed random-peptide libraries.

Sparks AB, Rider JE, Kay BK.

Methods Mol Biol. 1998;84:87-103. No abstract available.

PMID:
9666443
15.

Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.

Sparks AB, Morin PJ, Vogelstein B, Kinzler KW.

Cancer Res. 1998 Mar 15;58(6):1130-4.

16.

Identification of novel human WW domain-containing proteins by cloning of ligand targets.

Pirozzi G, McConnell SJ, Uveges AJ, Carter JM, Sparks AB, Kay BK, Fowlkes DM.

J Biol Chem. 1997 Jun 6;272(23):14611-6.

17.

Using molecular repertoires to identify high-affinity peptide ligands of the WW domain of human and mouse YAP.

Linn H, Ermekova KS, Rentschler S, Sparks AB, Kay BK, Sudol M.

Biol Chem. 1997 Jun;378(6):531-7.

PMID:
9224934
18.

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.

Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW.

Science. 1997 Mar 21;275(5307):1787-90.

19.

Isolation of a NCK-associated kinase, PRK2, an SH3-binding protein and potential effector of Rho protein signaling.

Quilliam LA, Lambert QT, Mickelson-Young LA, Westwick JK, Sparks AB, Kay BK, Jenkins NA, Gilbert DJ, Copeland NG, Der CJ.

J Biol Chem. 1996 Nov 15;271(46):28772-6.

20.

Binding properties of SH3 peptide ligands identified from phage-displayed random peptide libraries.

Hoffman NG, Sparks AB, Carter JM, Kay BK.

Mol Divers. 1996 Oct;2(1-2):5-12.

PMID:
9238627
21.

Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins.

Sparks AB, Hoffman NG, McConnell SJ, Fowlkes DM, Kay BK.

Nat Biotechnol. 1996 Jun;14(6):741-4.

PMID:
9630982
22.

Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.

Sparks AB, Rider JE, Hoffman NG, Fowlkes DM, Quillam LA, Kay BK.

Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1540-4.

23.

Screening phage-displayed random peptide libraries for SH3 ligands.

Sparks AB, Adey NB, Quilliam LA, Thorn JM, Kay BK.

Methods Enzymol. 1995;255:498-509. No abstract available.

PMID:
8524137
24.

Identification and characterization of Src SH3 ligands from phage-displayed random peptide libraries.

Sparks AB, Quilliam LA, Thorn JM, Der CJ, Kay BK.

J Biol Chem. 1994 Sep 30;269(39):23853-6.

25.

Molecular resurrection of an extinct ancestral promoter for mouse L1.

Adey NB, Tollefsbol TO, Sparks AB, Edgell MH, Hutchison CA 3rd.

Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1569-73.

Supplemental Content

Loading ...
Support Center